Vaccine News

Vaccine News

Vaccine iNews is a new segment dedicated to progress about about COVID-19 vaccines. and other vaccines. Currently there is a lot of controversy and issues surrounding COVID-19 vaccines and this new segment will not only address these but also provides updates about COVID-19 vaccines developments and progress. There are almost close to 168 COVID Vaccines being developed but 3 of the main covid-19 ...

Coronavirus News: Frequent Reformulation Of COVID-19 Vaccines Will Be Required As Studies Shows Coronaviruses Display Constant Adaptive Evolution

Source: Coronavirus News Nov 15, 2020 4 years ago

Coronavirus News: Even if any of the current COVID-19 vaccines under development is able to offer only short-term protection against certain strains of the SARS-CoV-2 coronavirus without causing any long term adverse effects such as ADE (Antibody-dependent enhancement) or other issues, the vaccines will need to be constantly reformulated as emerging studies show that the coronaviruses are constant...

Vaccine News: Brazil Suspends Clinical Trials Of Chinese COVID-19 Vaccine Called Coronavac made By Sinovac Biotech

Source: Vaccine News Nov 10, 2020 4 years ago

Vaccine News: Another latest development in the trillion dollar COVID-19 vaccine sector that is plagued with scams, lies, cover-ups and greed as Brazil announces a sudden suspension of all clinical trials involving the Chinese COVID-19 vaccine called Coronavac made by Sinovac Biotech. 24 hours ago, Brazil's health regulator said it had suspended clinical trials of a Chinese-developed ...

COVID-19 Vaccine: More American Scams? Pfizer Announces Preliminary Results That Suggested Their Vaccine Was More Than 90 Percent Effective!

Source: COVID-19 Vaccine Nov 10, 2020 4 years ago

COVID-19 Vaccine: American headquartered pharmaceutical giant Pfizer spend a fortune on a PR conference and paying off numerous unethical media writers and media to do an elaborate piece about its vaccine which it claims is more than 90 percent effective. In the last few hours its stocks were rallying and God knows who is going to make millions but the key issue is that there were no published stu...

Vaccine News: WTF! Now Dr Anthony Fauci From NIH Says That COVID-19 Vaccines Might Only Prevent Symptoms, Not the Virus!

Source: Vaccine News Nov 04, 2020 4 years ago

Vaccine News: As an individual that has been observing with skepticism the vaccines and therapeutic programs initiated in America under the corrupted and incompetent Trump administration and Dr Anthony Fauci with so many other scammers in play including a group of clandestine businessmen and billionaires headed by Tom Cahill and Nick Ayers, an aide of Mike Spence, it shocking to see that the trill...

BREAKING! COVID-19 Scams: British Medical Journal Says Current COVID-19 Vaccine Clinical Trials Cannot Tell Us If These Vaccines Will Save Lives!

Source: COVID-19 Scams Oct 22, 2020 4 years ago

COVID-19 Scams: Associate Editor at the British Medical Journal (BMJ) Professor Dr Peter Doshi, in a daring but truthful revelation yesterday warned that vaccine trials currently underway are not designed to tell us if they will save lives. https://www.bmj.com/content/371/bmj.m4037 Although several COVID-19 vaccine trials are now in their most advanced phase 3 stage, but what will i...

Vaccine News: Participant In Oxford University And AstraZeneca’s COVID-19 Vaccine Trial In Brazil Dies!

Source: Vaccine News Oct 22, 2020 4 years ago

Vaccine News: Brazil's health authority Anvisa reported that Brazilian volunteer participating in clinical trials of the COVID-19 vaccine developed by Oxford University and AstraZeneca has died on the 18th of October. It was unclear whether the volunteer had received the vaccine or a placebo and in countries like Brazil, the organizers can easily switch the facts in or...

China's COVID-19 Vaccine BBIBP-CorV Based On Inactivated Whole SARS-CoV-2 Virus Shows To Be A Safe Promising Candidate For Short Term Protection

Source: Vaccine-COVID-19 Oct 16, 2020 4 years ago

Vaccine-COVID-19: As more studies are showing that antibodies will ultimately only provide short term optimal protection of anything between 10 to 16 weeks and while at the same time other studies are also showing that many AAV (Adeno Associated Virus) vector RNA vaccines that are currently being developed and are in phase 3 trials might actually cause certain adverse effects https://www.thailandm...

BREAKING! Vaccine News: Johnson & Johnson Halts COVID-19 Vaccine Trial As Participant Becomes Seriously Sick

Source: Vaccine News Oct 13, 2020 4 years ago

Vaccine News: Pharmaceutical giant Johnson & Johnson announced on late Monday that it had temporarily halted its COVID-19 vaccine trial because one of its participants had become seriously sick. A spokesman for Johnson and Johnson told Thailand Medical News, "We have halted further dosing in all our COVID-19 vaccine candidate clinical trials globally due to a particpant...

COVID-19 Help: COVID-19 Pandemic Being Approached Wrongly! Emphasis Should Be On Multi-Drug Treatments and Genomics Not Vaccines And Antibodies

Source: COVID-19 Help Oct 11, 2020 4 years ago

COVID-19 Help: While tens of thousands are getting infected daily and thousands are dying each day, millions elsewhere are worried and are trying to find ways to help themselves and their loved ones and the only thing that stupid health authorities and incompetent corrupted governments around the world are doing are giving false hopes by an anticipated COVID-19 vaccine that many think will solve t...

MUST READ! Study Involving Case Of Reinfection Questions Efficacy Of COVID-19 Vaccines Under Development Or Trials Against Emerging Mutated Strains

Source: COVID-19 Vaccines Oct 08, 2020 4 years ago

COVID-19 Vaccines: A group of American researchers from the Swedish Medical Center-Seattle, University of Washington-Seattle, Stanford University-California, LabCorp-Seattle and the Vaccine and Infectious Disease Division, Fred Hutch-Seattle after reviewing a case of a patient who got re-infected with a different strain of the SARS-CoV-2 coronavirus ie the more potent and infectious D614G mu...

Vaccine News: Harvard Study Leads To a More Effective And Safer Vaccine Platform Utilizing Red Blood Cells To Elicit Specific Immune Responses

Source: Vaccine News Oct 05, 2020 4 years ago

Vaccine News: Researchers from Harvard’s Wyss Institute for Biologically Inspired Engineering and John A. Paulson School of Engineering and Applied Sciences (SEAS) along with support from Perelman School of Medicine, University of Pennsylvania, have developed a platform technology that uses red blood cells to deliver antigens to antigen-presenting cells (APCs) in the spleen, generating ...

Medical Law: DIY Or Do-It-Yourself COVID-19 Vaccines Fraught With Legal, Ethical, and Public Health Issues Warns Law Professor At University Of Illinois

Source: Medical Law Oct 02, 2020 4 years ago

Medical Law: According to a new research paper in the journal Science co-written by a University of Illinois, Urbana-Champaign legal expert who studies the policy implications of advanced biotechnologies. well-intentioned “citizen scientists” developing homemade COVID-19 vaccines may believe they are inoculating themselves against the ongoing pandemic, but the pract...

Vaccines-COVID-19: Phase 1 Trial Results Of NIAID And Moderna New COVID-19 mRNA-1273 Vaccine Shows Promise In Older Adults

Source: Vaccines-COVID-19 Oct 01, 2020 4 years ago

Vaccines-COVID-19: The NIAID And Moderna Inc Phase 1 clinical trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults. The trial results were published in the New England Journal of Medicine. https://www.nejm.org/doi/10.1056/NEJMoa2028436 The new experimental v...

BREAKING! COVID-19 Vaccine Exclusive: Possible Dangers Of Using Adeno-Associated Virus (AAV) Vectors For COVID-19 Vaccines

Source: COVID-19 Vaccine Exclusive Sep 29, 2020 4 years ago

COVID-19 Vaccine Exclusive: Adeno-associated viral vectors to deliver gene therapies and vaccines are a growing platform that is being used by more and more pharmaceutical companies in drug and vaccine development. But unknown to many there are possible repercussions taking such AAV vectors based meds or vaccines. Two gene therapies using adeno-associated virus (AAV) vectors to deliver ge...

BREAKING! AIDs Healthcare Foundation (AHF) Say Most COVID-19 Vaccine Trials By Developers Lack Transparency Especially Pfizer And AstraZenca

Source: COVID-19 Vaccine Sep 14, 2020 4 years ago

COVID-19 Vaccine : The AIDS Healthcare Foundation (AHF), the largest global AIDS organization, today (Monday,14th September) sharply criticized pharmaceutical and biotech companies working on COVID-19 vaccines over a near total lack of transparency on the companies’ respective trials, including setbacks with AstraZeneca’s vaccine trial that briefly forced its suspensio...

India's COVID-19 Vaccine Candidate Covaxin Or BBV152, Which Uses Inactivated Whole-Virion Shows Better Prospects Than RNA Vaccines

Source: Vaccines-COVID-19 Sep 14, 2020 4 years ago

Vaccines-COVID-19: Indian researchers from vaccine developer Bharat Biotech International Ltd in collaboration with researchers National Institute of Virology-Indian Council of Medical Research have conducted a preclinical study demonstrating the safety and efficacy of a new candidate vaccine against the SARS-CoV-2 coronavirus, the pathogen that causes the COVID-19 disease. The ...

Vaccines-COVID-19: First Oral COVID-19 Vaccine By Vaxart Inc Induces Potent Systemic and Mucosal Immune Responses in Preclinical Studies

Source: Vaccines-COVID-19 Sep 13, 2020 4 years ago

Vaccines-COVID-19: The world’s oral recombinant adenoviral mucosal COVID-19 vaccine by Vaxart, Inc, a California based biotechnology company that is administered by tablet rather than by injection, has demonstrated positive results in a inducing potent systemic and mucosal immune responses in preclinical studies. The study findings were published on a preprint server and are current...

COVID-19 Immunity Short-Lived For Those Who Are Asymptomatic Or Had Mild Symptoms. Doubts Raised About Ability Of Vaccines To Really Work

Source: COVID-19 Immunity Sep 09, 2020 4 years ago

COVID-19 Immunity is short-lived for those who had mild symptoms when they were first infected with the SARS-CoV-2 coronavirus or were asymptomatic according to a new study by Chinese researchers from the Army Medical University in Chongqing led by Dr Ye Lilin, a leading Immunologist from the University’s Institute of Immunology. The study also indicates that the absence of the key ...

BREAKING NEWS! Phase 3 Study Of Oxford’s And AstraZeneca’s COVID-19 Vaccine AZD1222 Immediately Stopped Due To Suspected Adverse Reactions

Source: Sep 09, 2020 4 years ago

Vaccine-COVID-19: It was announced the last few hours that the large phase 3 clinical trial of the COVID-19 vaccine AZD1222 developed by the University of Oxford and Astrazenaca was stopped in the last 24 hours and put on hold as a result of reported serious adverse reactions. The sudden stoppage affected numerous testing sites globally especially in the United States and United Kingdom a...

COVID-19 Next Generation Vaccines: Elicio Therapeutics Launching Clinical Trials Of Its ELI-005 Immunotherapy Based Lymph Node Targeting Vaccine

Source: COVID-19 Next Generation Vaccines Sep 07, 2020 4 years ago

COVID-19 Next Generation Vaccines: Cambridge based Elicio Therapeutics has developed a next generation COVID-19 vaccine ELI-005 that is expected to start initial clinical trials soon. Unlike most of the current genetic based vaccines under development or in phase 3 trials, this lymph node-targeting vaccine is composed of an adjuvant developed using the company’s Amphiphile technology and the...

Researchers from UK and Taiwan Develop New COVID-19 Vaccine RBD-SpyVLP Using Virus-Like Particle With Promising Results In Animal Studies

Source: COVID-19 Vaccine Sep 02, 2020 4 years ago

COVID-19 Vaccine researchers from UK and Taiwan have demonstrated the potential of a new candidate vaccine called RBD-SpyVLP against the SARS-CoV-2 coronavirus in animal models. In vivo trials involving animal models such as mice and pigs, low doses of the vaccine triggered a potent neutralizing antibody response that was stronger than the response induced by serum taken from patients who...

COVID-19 Vaccine: Researchers Identify T Cell Epitopes For Effective Vaccine Development

Source: COVID-19 Vaccine Aug 31, 2020 4 years ago

COVID-19 Vaccine: New studies are showing that T cell immunity is necessary to provide robust and durable protection against reinfection with the SARS-CoV-2 coronavirus. This implies that the epitopes specific to the SARS-CoV-2 coronavirus which are capable of eliciting this type of response across a huge number of individuals need to be identified. An epitope, also known as ant...

COVID-19 Vaccine: US FDA Says Early Approval For COVID-19 Vaccine Possible Even Before End Of Trials!

Source: COVID-19 Vaccine Aug 31, 2020 4 years ago

COVID-19 Vaccine: The chief of the US Food and Drug Administration, Dr Stephen Hahn raised the possibility that a vaccine against the SARS-CoV-2 coronavirus might be given emergency approval even before the end of trials designed to ensure its safety and effectiveness. However such a request for extraordinary approval would have to come from the vaccine developer, Dr Stephen Hah...

BREAKING! COVID-19 Vaccine: Details That Oxford COVID-19 Vaccine Uses Cell Lines From Aborted Babies Deeply Disturbs Australian Archbishop Over Deals

Source: COVID-19 Vaccine Aug 24, 2020 4 years ago

COVID-19 Vaccine: A media release by Agence France-Presse(AFP) reports that a senior Catholic archbishop has warned he is "deeply troubled" by Australia's vaccine deal with AstraZeneca, saying the potential vaccine uses a fetal cell line that creates an "ethical quandary" for Christians. This is the first time that Thailand Medical News is aware that fetal cell lin...

COVID-19 Vaccine: Washington University’s Nasal Vaccine Shows Preventive Effectiveness In Mice, Study Progresses To Non-Human Primates

Source: COVID-19 Vaccine Aug 22, 2020 4 years ago

COVID-19 Vaccine: Researchers from Washington University School of Medicine-St. Louis have developed a vaccine that targets the SARS-CoV-2 coronavirus and can be administered through the nose in one dose. Studies in mice models susceptible to the SARS-CoV-2 coronavirus have proven to be effective in preventing infection. The study team next plans to test the vaccine in nonhuman pri...

COVID-19 Vaccines: Pfizer And BioNTech Releases Additional Data On COVID-19 Vaccine Candidate BNT162b2 Early Study Results

Source: COVID-19 Vaccines Aug 21, 2020 4 years ago

COVID-19 Vaccines: Pfizer Inc. and BioNTech has released additional Phase 1 safety and immunogenicity data from their ongoing U.S. study of the BNT162 mRNA-based vaccine program against SARS-CoV-2, which has advanced into Phase 2/3 evaluation. The clinical data is published on a preprint server and is pending peer-review. https://www.medrxiv.org/content/10.1101/2020.08...

COVID-19 Vaccine: Washington University’s Genetically Modified Virus Based Vaccine Shows Promise In Mice And Prevents Severe Disease Progression

Source: COVID-19 Vaccine Aug 13, 2020 4 years ago

COVID-19 Vaccine: A new vaccine made from a mild virus genetically modified to carry a key gene from the SARS-CoV-2 coronavirus is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to research findings from Washington University School of Medicine in St. Louis. Co-senior author Dr Michael S. Diamond, MD, PhD, the Herbert S. Gasser Profess...

COVID-19 Vaccine: New Generation NovaVax’s NVX-CoV2373 Recombinant Particle Vaccine Shows Encouraging Results In Phase I Trial

Source: COVID-19 Vaccine Aug 10, 2020 4 years ago

COVID-19 Vaccine: Results of the phase one trial of NovaVAx’s NVX-CoV2373 recombinant nanoparticle vaccine that is manufactured at Emergent Biosolutions, was found to be well tolerated and immunogenic including inducing T-cell response and neutralization antibodies four-fold higher than the mean observed in hospitalized COVID-19 patients. Though several promising candidates are already on...

COVID-19 Vaccine: Novel Intranasal Vaccine Platform Offers Opportunities For More Effective Vaccines With Lesser Side Effects

Source: COVID-19 Vaccine Aug 09, 2020 4 years ago

COVID-19 Vaccine: Biotech and medical researchers from the University of Chicago and Duke University have created a new vaccine technology platform that allows the generation of the more effective vaccines with the fewest side effects using self-assembling peptide nanofibers tagged with antigens to prime the immune system against a potential invasion. The research findings were published ...

COVID-19 Vaccines Most Likely To be Ineffective For Obese Individuals. America Likely To Be In Trouble With Over 42 Percent Of The Population Obese!

Source: COVID-19 Vaccines Aug 07, 2020 4 years ago

COVID-19 Vaccines: As the world eagerly anticipates the arrival of a truly effective COVID-19 vaccine, it is emerging that one country is most likely to least benefit from it despite spending the most money compared to any other country in the world to secure a sufficient supply of the vaccine for its population. In the United States where more than 42 percent of its population is obese, ...

COVID-19 Vaccine: Novavax's COVID-19 Vaccine NVX-CoV2373 Phase I Trial Meets Endpoint Expectations

Source: COVID-19 Vaccine Aug 06, 2020 4 years ago

COVID-19 Vaccine: Maryland-based Novavax is yet another biopharma company reporting promising early-stage data for a potential COVID-19 vaccine. The biopharma company announced data from Phase I of its Phase I/II placebo-controlled trial of its vaccine with and without Matrix-M adjuvant. The trial was conducted in healthy adults 18 to 59 years of age. The vaccin...

COVID-19 Vaccine: Russia Announces Mass COVID-19 Vaccination Program in October Despite Lack Of Any Proper Clinical Trials!

Source: COVID-19 Vaccine Aug 04, 2020 4 years ago

COVID-19 Vaccine: Russia’s Minister for Health Mikhail Murashko announced that Russia is planning a nationwide program to vaccinate its population against COVID-19 starting in October. The vaccine has not yet completed clinical trials. Murashko indicated they would begin by vaccinating teachers and health care workers. He also told the RIA state news agency that while in t...

BREAKTHROUGH! COVID-19 Vaccines: ImmunityBio Inc. And Icahn Develop Next Generation Bivalent hAd5 Vaccine That Elicits Rapid T-Cell And Antibody Response

Source: COVID-19 Vaccines Aug 03, 2020 4 years ago

COVID-19 Vaccines: American researchers from ImmunityBio Inc. and Icahn School of Medicine at Mount Sinai in New York have developed a next generation COVID-19 vaccine: the bivalent human adenovirus serotype 5 (hAd5) vaccine for inducing both cellular and humoral immunity against the SARS-CoV-2 coronavirus, using both an S protein sequence optimized for cell surface expression...

COVID-19 Vaccines: Study Shows Moderna’s mRNA-1273 Development Stage Vaccine Protects Upper And Lower Airways In Nonhuman Primates

Source: COVID-19 Vaccines Jul 29, 2020 4 years ago

COVID-19 Vaccines: Research scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health report that two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19) induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2. ...

COVID-19 Vaccine News: US-Based Dynavax Partners With Taiwan’s Medigen To Develop New Adjuvanted COVID-19 Vaccine

Source: COVID-19 Vaccine News Jul 26, 2020 4 years ago

COVID-19 Vaccine News: Dynavax Technologies, a fully-integrated biopharmaceutical based in California has partnered with Taiwan-based Medigen Vaccine Biologics to develop a new adjuvanted Covid-19 vaccine candidate. The new collaborative vaccine development will leverage on Medigen’s stable prefusion form of the SARS-CoV2 recombinant spike protein in combination with Dynavax&rs...

COVID-19 Vaccine: Arcturus Therapeutics And Duke-NUS Medical School’s LUNAR-COV19 Vaccine Secures Approval For Clinical Trials In Singapore

Source: COVID-19 Vaccine Jul 23, 2020 4 years ago

COVID-19 Vaccine: California based Arcturus Therapeutics Holdings Inc., a clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, and Duke-NUS Medical School, Singapore's flagship research-intensive graduate entry medical school, announced that the Clinical Trial Application for COVID-19 vaccine ...

COVID-19 Vaccine Progress: BioNTech And Pfizer’s BNT162b1 RNA-Based Vaccine Elicits T Cell And Neutralizing Antibodies Response In Phase 1/2 Trial

Source: COVID-19 Vaccine Progress Jul 22, 2020 4 years ago

COVID-19 Vaccine Progress: The Phase ½ clinical trial of BioNTech And Pfizer’s BNT162b1 RNA-Based Vaccine has demonstrated that the vaccine is able to elicit both T Cell And Neutralizing Antibodies Response. The trial results were published by researchers from Germany and the United States on a preprint server and are yet to have been peer-reviewed. https://www.medrxiv.org/co...

COVID-19 Vaccine: Phase I/II Of Oxford University And AstraZenaca’s ChAdOx1 Vaccine Produces Strong Immune Response, Early Results Show

Source: COVID-19 Vaccine Updates Jul 21, 2020 4 years ago

COVID-19 Vaccine Updates: The clinical trial results of the Phase I/II trial of Oxford University and AstraZenaca’s ChAdOx1 nCoV-19 vaccine published in the scientific journal, The Lancet, indicate no early safety concerns and induces strong immune responses in both parts of the immune system. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31604-4/fulltext The ChA...

COVID-19 Vaccine: Chinese Ad5 Vectored COVID-19 Vaccine Progresses To Phase 3 As Phase 2 Trial Results Claim To Be Safe and Induces Immune Response

Source: COVID-19 Vaccine Jul 21, 2020 4 years ago

COVID-19 Vaccine: The phase 2 trial of China’s Ad5 vectored COVID-19 vaccine candidate that was conducted in Wuhan has found that the vaccine is safe and induces an immune response, according to trial findings published in The Lancet. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31605-6/fulltext#%20 The phase 2 randomized trial sought to evaluate the ...

BREAKING! COVID-19 Vaccine: As Chinese Vaccine Developer Sinopharm Starts Phase 3 Trial In Abu Dhabi, Angry Devout Muslims Are Asking How Halal Are These Vaccines?

Source: COVID-19 Vaccine Jul 19, 2020 5 years ago

COVID-19 Vaccine: It was announced that the First Phase-III clinical trial of Chinese state-owned pharmaceutical company Sinopharm's inactivated Covid-19 vaccine has started in Abu Dhabi. Head of Abu Dhabi’s health department becomes first volunteer for Covid-19 Phase III Chinese vaccine trials Interestingly the UAE health authorities recently issued a permit for up to 15,000 vo...

COVID-19 Vaccine: Moderna’s mRNA 1273 Vaccine Progresses To Phase III After Successful Early Clinical Results

Source: COVID-19 Vaccine Jul 17, 2020 5 years ago

COVID-19 Vaccine: Moderna has announced that said its COVID-19 vaccine candidate mRNA-1273 will advance to a 30,000-participant Phase III trial later this month, following publication of additional positive Phase I data from a study led by the NIH’s National Institute of Allergy and Infectious Diseases (NIAID). The “COVE” Phase III study (NCT04470427) is expected to begin regis...

COVID-19 Vaccine Updates: Astrazeneca's COVID-19 Vaccine Performs Well In Phase 1 Trial, Generating Antibodies And T-Cells Against SARS-Cov-2

Source: COVID-19 Vaccine Jul 17, 2020 5 years ago

COVID-19 Vaccine Updates: Data from the Phase 1 trial of COVID-19 vaccine by AstraZeneca and Oxford University’s Jenner Institute is showing a robust defense against the novel coronavirus that has infected more than 13.6 million individuals across the globe U.K. media yesterday began to report hints of data from the early-stage study of the vaccine candidate...

COVID-19 Vaccine: US NIH Study On Experimental COVID-19 Vaccine mRNA-1273 Claims To Show Safe Immune Response

Source: COVID-19 Vaccine Jul 15, 2020 5 years ago

COVID-19 Vaccine: The Phase 1 trial of an investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes COVID-19 disease, was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to US NIH authorities. The interim results of the trial were published yesterday in The New England Journal of Medicine....

COVID-19 Vaccine: Canadian Biopharmaceutical Company Medicago Launches Phase I Trial for Plant-Derived COVID-19 Vaccine Candidate

Source: COVID-19 Vaccine Jul 15, 2020 5 years ago

COVID- 19 Vaccine: Canadian biophamaceutical company Medicago that is based in Quebec with branches in the U.S. announced that it has begun Phase I clinical trial for its plant-derived COVID-19 vaccine candidate. It has already administered the first doses of the candidate in healthy human subjects, and the company intends to initiate a Phase II/III trial this coming October. Dr Nath...

BREAKING! COVID-19 Vaccine: New Discovery About SARS-CoV-2 Cold Sensitivity For Survival Adaptivity Could Impact Vaccine Studies And Developments

Source: COVID-19 Vaccine Jul 15, 2020 5 years ago

COVID-19 Vaccine: American researchers from Duke University-Durham have made an important discovery about the spike protein SARS-CoV-2 that could have a broad impact on vaccine studies. The S or spike protein is the structure that binds to host cell angiotensin-converting enzyme 2 (ACE2) to enable viral attachment and entry during the infection process. The spike protein is also...

MUST READ! COVID-19 Vaccine: Researchers Warn Rush To Develop Vaccine Could Backfire.Dangerous Antibody-Dependent Enhancement (ADE) Could Occur

Source: COVID-19 Vaccine Jul 14, 2020 5 years ago

COVID-19 Vaccine: There are more than 140 SARS-CoV-2 vaccines in development and the race for a successful candidate to help prevent COVID-19 is making many researchers jumpstart processes and in some cases even by pass safety protocols. Although an effective and safe vaccine would be a major advance in the fight against COVID-19, there are challenges in evaluating the efficacy of&nb...

COVID-19 Vaccine: Pre Clinical Testing Of Altimmune’s AdCOVID Intranasal Vaccine At University Of Alabama Birmingham Shows Positive Results

Source: COVID-19 Vaccine Jul 13, 2020 5 years ago

COVID-19 Vaccine: Maryland based Altimmune, Inc., a clinical-stage biopharmaceutical company, has reported positive results from the preclinical studies conducted in mice at the University of Alabama at Birmingham of its intranasal COVID-19 vaccine candidate, AdCOVID. The research studies; a collaboration between the University of Alabama-Birmingham and Altimmune showed strong serum neutr...

COVID-19 Vaccines: NIAID Creates Clinical Trials Network As Vaccine Trials Nationwide Facing Problems Getting Volunteers Or Patients To Enroll

Source: COVID-19 Vaccines Jul 10, 2020 5 years ago

COVID-19 Vaccines: The U.S.National Institute of Allergy & Infectious Diseases (NIAID) has founded a new clinical trials network focused on enrolling volunteers in clinical trials for COVID-19 vaccines and monoclonal antibodies. Various media have recently reported that sponsor companies are struggling to enroll patients in clinical trials for COVID-19 va...

COVID-19 Vaccine Updates: Novavax Secures US$1.6 Billion in “Warp Speed” Funding, To Start Production Of 100 Million Doses of NVX-CoV2373 Vaccine

Source: COVID-19 Vaccine Updates Jul 08, 2020 5 years ago

COVID-19 Vaccine Updates: Maryland based Biotech company Novavax announced that it has been awarded US$1.6 billion toward late-stage clinical trials and large-scale manufacturing to produce 100 million doses of its COVID-19 vaccine starting this year through the Trump’s administration “Operation Warp Speed” program. The new funding will enable Novavax to complete la...

COVID-19 Vaccine News: Johnson And Johnson Contracts Emergent BioSolutions For 5 Year, I Billion Doses Of Ad26.COV2-S Vaccine Manufacturing Deal

Source: COVID-19 Vaccine News Jul 07, 2020 5 years ago

COVID-19 Vaccine News: Biotech manufacturing company-Emergent BioSolutions, based in Maryland, entered a five-year manufacturing services deal with Janssen Pharmaceutical, a Johnson & Johnson company, to manufacture J&J’s Ad26.COV2-S COVID-19 vaccine. Emergent will handle contract development and manufacturing (CDMO) services in a deal that is valued at ...

COVID-19 Vaccine Updates: South Australia’s Flinders University Commences Phase 1 Trial Of COVID-19 Vaccine COVAX-19 Developed By Vaxine Pty Ltd

Source: COVID-19 Vaccine Updates Jul 07, 2020 5 years ago

COVID-19 Vaccine Updates: It was announced that vaccine candidate COVAX-19 developed by Vaxine Pty Ltd and Flinders University will commence Phase 1 trials at the Royal Adelaide Hospital (RAH) to test its efficacy. The phase I trial will provide initial safety and immune response data on 40 healthy participants aged between 18 and 65 years who have already been pre-screened. Resear...

COVID-19 Vaccine: Oxford’s and AstraZenaca’s ChAdOx1 Vaccine Progresses Into Phase III Human Trials

Source: COVID-19 Vaccine Jul 06, 2020 5 years ago

COVID-19 Vaccine: Professor of vaccinology at the University of Oxford, and one of the scientists leading the vaccine initiative, Dr Sarah Gilbert, told the U.K.'s Science and Technology Committee last week that their candidate vaccine has progressed to the phase III trial in the United Kingdom. Phase III trials typically involves tens of thousands of research participants acros...

COVID-19 Vaccine: China Creates Artificial Protein That Can Be Basis For Broad-Spectrum Vaccine While Others Warn Vaccines Might Not Be Effective Long Term

Source: COVID-19 Vaccine Jul 05, 2020 5 years ago

COVID-19 Vaccine: Researchers from China have created an artificial protein that they say could be the basis of a vaccine to help ward off various deadly coronaviruses, including the pathogen that causes Covid-19 Copyright: Credit: Xinhua The researchers from the Chinese CDC said the approach triggered a strong antibody response in mice and monkey trials to Middle Eas...

COVID-19 Vaccine: India’s Second COVID-19 Vaccine By Zydus Cadila Gets Approval For Human Trials

Source: COVID-19 Vaccine Jul 04, 2020 5 years ago

COVID-19 Vaccine: Indian pharmaceutical company, Zydus Cadila received the green signal from the Drug Controller General of India (DGCI) to start phase I and II of their clinical trials on human participants. Over 120 independent scientific bodies are in contention to find a potential COVID-19 vaccine. Over 7 vaccines are being researched in India and just this week, two candidate groups ...

COVID-19 Vaccine Updates - Pfizer and BioNTech Publish Positive Interim Phase I/II Data for COVID-19 Vaccine

Source: COVID-19 Vaccine Updates Jul 04, 2020 5 years ago

COVID-19 Vaccine Updates: Pharmaceutical and Biotech giants, Pfizer and BioNTech reported that the most advanced of four constructs of their messenger RNA (mRNA) vaccine candidate for COVID-19 showed encouraging immunogenicity and a favorable safety profile in preliminary Phase I/II data published in a preprint study. https://www.medrxiv.org/content/10.1101/2020.06.30.20142570v1 Bot...

Interesting Reads

SARS-CoV-2 XEC Variant Shows Enhanced Immune Evasion through NTD Glycosylation

Nikhil Prasad
Oct 24, 2024 2 months ago

Many exposed to COVID-19 will develop Acute Ischemic Colitis!

Nikhil Prasad
Oct 21, 2024 2 months ago

Breaking News! Study Reveals Potential New Form of Brain Neurodegeneration Linked to COVID-19!

Nikhil Prasad
Oct 02, 2024 3 months ago

Word-Finding Challenges Linked to Post-COVID-19 Syndrome

Nikhil Prasad
Oct 02, 2024 3 months ago

Italian study discovers new subtype of T-cells as immune players in COVID-19

Nikhil Prasad
Sep 29, 2024 3 months ago

Texas scientist warns of new SARS-CoV-2 neuroinvasion pathway involving the trigeminal nerve

Nikhil Prasad
Sep 26, 2024 3 months ago

Researchers warn that SARS-CoV-2 can infect the Meibomian glands of the eyes

Nikhil Prasad
Jul 26, 2024 5 months ago

SARS-CoV-2 spike protein accelerates aging of blood vessels

Nikhil Prasad
Jul 23, 2024 5 months ago

Forget about the KP.3, LB.1, KP.2.3 variants. The new SARS-CoV-2 KP.3.1.1 is leading the current global COVID-19 surge

Nikhil Prasad
Jul 21, 2024 5 months ago

SARS-CoV-2 Causes ACE2 Downregulation and Unique Fibrosis That Contribute to Long COVID-19

Nikhil Prasad
Jun 28, 2024 6 months ago

COVID-19 and Stroke: New Insights on Inflammation and Recovery

Nikhil Prasad
Jun 22, 2024 6 months ago

Herbs And Phytochemicals: Oleuropein From Olive Leaf Can Help Against Colorectal Cancer

Nikhil Prasad
Jun 15, 2024 6 months ago

COVID-19 News: Researchers Warn That SARS-CoV-2 Infections Can Lead To Splenic Infarctions!

Nikhil Prasad
Dec 14, 2023 1 year ago

BREAKING COVID-19 News! SARS-CoV-2 Affects Red Blood Cell Morphology!

Nikhil Prasad
Oct 04, 2023 1 year ago

Study Shockingly Shows That Many Exposed To The SARS-CoV-2 Omicron Variant Exhibit Hematuria And Proteinuria! Early Signs Of Possible Kidney Damage?

COVID-19-News-Omicron-Hematuria-Proteinuria-Kidney-Damage
May 30, 2023 2 years ago

Phenolic Phytochemicals From The Roselle Plant Or Hibiscus Sabdariffa (Thai: Krachiap กระเจี๊ยบ) Can Treat And Prevent Obesity

Herbs And Phytochemicals - Roselle - Obesity
Mar 08, 2023 2 years ago

COVID-19 News: Will SARS-CoV-2 Infections Ultimately Lead To An Increased Incidence Of Head And Neck Cancers?

COVID-19 News - Head And Neck Cancers - By Nikhil P & Kittisak M
Feb 02, 2023 2 years ago

Study Validates Previous Findings That SARS-CoV-2 Reinfections Are Now Occurring At Shorter Intervals. Current CDC and ECDC Reinfection Definitions Are Obsolete!

Source: Medical News - SARS-CoV-2 Reinfections - Omicron
Sep 28, 2022 2 years ago

Quercetin Emerging As One Of The Must Take COVID-19 Supplements Especially When Considering The Omicron Variant And Long COVID-19 Issues

Source: COVID-19 Supplements - Quercetin
Jan 02, 2022 3 years ago

BREAKING! New International Study Warns That SARS-CoV-2 Infections Will Lead To Cancers Especially Colorectal Cancers Due to Disruption In Autophagy!

Source: SARS-CoV-2-Cancer
Nov 18, 2021 3 years ago

BREAKING! COVID-19 Genetics: Yale Scientist Identify Eight ‘Super’ Genetic Variants In White People That Increases COVID-19 Death Risk!

Source: COVID-19 Genetics
Nov 13, 2020 4 years ago

Japanese Study Shows That Ozone Water Rapidly Inactivates SARS-Cov-2 Coronavirus, Making It An Ideal COVID-19 Disinfectant And Sanitizer

Source: Ozone Water-COVID-19
Nov 05, 2020 4 years ago

BREAKING NEWS! COVID-19 Study Reveals That SARS-CoV-2 Uses CD4 Cells To Infect T-helper Lymphocytes. COVID-19 A Potent Version Of Airborne HIV?

Source: BREAKING NEWS
Sep 30, 2020 4 years ago

COVID-19 News: Emerging Studies Shows SARS-CoV-2 Attacks The Digestive Tract Especially The Intestines Directly, Reported Case Of Bowel Perforation

Source: COVID-19 News
Sep 21, 2020 4 years ago

BREAKING NEWS! Study Of COVID-19 Recovered Patients In China Reveals That Lymphocytes Are Drastically Altered To Become Dysfunctional With Immunity Implications

Source: COVID-19 Recovered Patients
Jul 02, 2020 5 years ago

Occulus Hirsutus and AQCH: India Discreetly Developing And Testing COVID-19 Drug Based On Phytochemicals Extracted From Occulus Hirsutus Plant

Source: Occulus Hirsutus and AQCH
Jun 27, 2020 5 years ago

High-Flow Nasal Cannula: For COVID-19 Second Wave Preparations, Forget About Ventilators, Doctors Are Now Turning To High-Flow Nasal Cannula

Source: High-Flow Nasal Cannula
Jun 25, 2020 5 years ago

BREAKING! Androgens: Study Shows Bald Men Mostly Likely To Suffer Severe COVID-19 Conditions Due To High Levels Of Androgens

Source: Androgens And COVID-19
Jun 23, 2020 5 years ago

BREAKING NEWS! COVID-19 Research Shows That SARS-CoV-2 Coronavirus Can Survive In Water For Up To 25 Days And Could Also Be Water-Borne

Source: COVID-19 Research
Jun 23, 2020 5 years ago

BREAKING! Hepatitis B: UAE COVID-19 Case Study Indicates That COVID-19 Could Induce Hepatitis B Virus Reactivation

Source: Hepatitis B and COVID-19
Jun 21, 2020 5 years ago

BREAKING! COVID-19 Research: Sodium Channels Could Be Affected As Coronavirus Spike Protein Has Similar Sequence To Human Epithelial Sodium Channel

Source: COVID-19 Research
Jun 21, 2020 5 years ago

BREAKING! Cannabis And COVID-19: Caflanone, A Flavonoid Extracted From A Distinct Cannabis Strain Could be A Therapeutic Drug Against the COVID-19

Source: Cannabis And COVID-19
Jun 20, 2020 5 years ago

Gargling: New Studies Show That Throat Gargling May Be Beneficial After All During COVID-19 Despite Being Labeled In the Past As Misinformation

Source: Gargling and COVID-19
Jun 19, 2020 5 years ago

BREAKING! COVID-19 Research: New Study Reveals That SARS-CoV-2 Coronavirus Also Affects Thyroid Functions In Majority Of COVID-19 Patients

Source: COVID-19 Research
Jun 17, 2020 5 years ago

Exploring Inhaled Nitric Oxide (iNo) As As An Adjuvant COVID-19 Treatment For Pulmonary Issues

Source: Nitric Oxide and COVID-19
Jun 15, 2020 5 years ago

Understanding The Differences Between COVID-19 Asymptomatic and Presymptomatic Conditions

Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020 5 years ago

Scripp Institute Has Detected The Mutation That Most Scientist Dread: The D614G Mutation Which Could Make The SARS-CoV-2 More Infectious

Source: SARS-CoV-2 Mutations
Jun 13, 2020 5 years ago

BREAKING! Medical Experts Warn That COVID-19 Could Trigger Diabetes In Otherwise Healthy Individuals Who Never Had The Condition Before.

Source: Diabetes and COVID-19
Jun 13, 2020 5 years ago

Acute Pancreatitis: Warning That Acute Pancreatitis Is Now Manifesting In COVID-19 Patients, A Condition Never Seen In Early Stages Of The Pandemic

Source: Acute Pancreatitis
Jun 11, 2020 5 years ago

Immune Health: Cistanche And Pu-erh Tea Supplements Could Help Improve Immune Factors And Reduce Pro-inflammatory Cytokines Such As Interleukin-6

Source: Immune Health
Jun 09, 2020 5 years ago

Study Finds That COVID-19 Also Causes Myocardial Injury (Heart Damage)

Source: Myocardial Injury
Jun 09, 2020 5 years ago

European COVID-19 Research Indicates That Individuals With Blood Group Type A Might Be More Vulnerable To Respiratory Failure

Source: COVID-19 Research
Jun 08, 2020 5 years ago

Supplements: Singaporean Researchers Say That Vitamin D, Magnesium And Vitamin B12 Combo May Reduce Severity In Older COVID-19 Patients

Source: Supplements And COVID-19
Jun 06, 2020 5 years ago

MUST READ! Strokes: Study Shows COVID-19 Increases Risk Of Strokes In Healthy Young Individuals. Global Increase In Stroke Deaths Last Few Months

Source: Strokes And COVID-19
Jun 05, 2020 5 years ago

BREAKING ALERT! COVID-19: Italian Researchers Discover Brain Lesions On COVID-19 Patients

Source: COVID-19
May 23, 2020 5 years ago

FROM WEIGHT LOSS NEWS

LATEST ON MEDICAL THAILAND

World COVID-19 News

COVID-19 Diagnostics

COVID-19 Drugs

COVID-19 Supplements

COVID-19 Herbs

COVID-19 Disinfectants

COVID-19 Mutations

COVID-19 Research

COVID News

Long COVID

COVID-19 Vaccines

COVID-19 Clinical Care

Medical Press Releases

Medical Innovations & Startups

AI in Medicine

Thailand Biotech News

Medical Spheres Bulletins

Medical White Papers

Medical Packages

Medical Tips

Medical Support Groups

MOST READ

Interesting Reads

FROM WEIGHT LOSS NEWS

LATEST ON MEDICAL THAILAND